Published in Antimicrob Agents Chemother on June 01, 1997
Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev (2007) 15.66
Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev (1998) 9.76
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol (2010) 2.89
Candidemia in Norway (1991 to 2003): results from a nationwide study. J Clin Microbiol (2006) 1.63
Restriction enzyme analysis of ribosomal DNA shows that Candida inconspicua clinical isolates can be misidentified as Candida norvegensis with traditional diagnostic procedures. J Clin Microbiol (2003) 1.15
Invasive Candidiasis due to Candida Norvegensis in a Liver Transplant Patient: Case Report and Literature Review. Infect Dis Rep (2014) 0.75
Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol (1994) 5.33
Standardization of antifungal susceptibility testing. J Antimicrob Chemother (1996) 1.73
Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1990) 1.16
Invasive Candida norvegensis infection in immunocompromised patients. Scand J Infect Dis (1996) 1.00
Isolation of Candida norvegensis from clinical specimens: four case reports. Clin Infect Dis (1996) 0.96
[Study of a Norwegian collection of yeasts]. Ann Parasitol Hum Comp (1954) 0.90
Risk factors for sporadic Campylobacter infections: results of a case-control study in southeastern Norway. J Clin Microbiol (1992) 3.18
Yersinia enterocolitica in drinking-water. Scand J Infect Dis (1972) 2.79
[Supplement to the antigenic schema of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1972) 2.52
Rapid identification of gram-negative rods using a three-tube method combined with a dichotomic key. Acta Pathol Microbiol Scand Suppl (1975) 1.98
Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. The Norwegian Yeast Study Group. Antimicrob Agents Chemother (1993) 1.93
Classification of coagulase-negative staphylococci in the diagnostic laboratory. Acta Pathol Microbiol Scand B (1977) 1.80
Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis. Antimicrob Agents Chemother (1993) 1.77
Evaluation of urine sampling technique: bacterial contamination of samples from women students. Br J Gen Pract (1992) 1.75
Meningococcal phenotypic and genotypic characteristics and human antibody levels. J Clin Microbiol (1988) 1.65
Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group. J Clin Microbiol (1998) 1.55
Transfer of penicillin G and ampicillin into human skin blisters induced by suction. Scand J Infect Dis Suppl (1978) 1.36
Construction of a dense SNP map for bovine chromosome 6 to assist the assembly of the bovine genome sequence. Anim Genet (2008) 1.36
Rapid identification of prompt lactose-fermenting genera within the familyh Enterobacteriaceae. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.36
Relationship of virulence-associated autoagglutination to hemagglutinin production in Yersinia enterocolitica and Yersinia enterocolitica-like bacteria. Infect Immun (1983) 1.35
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state. J Antimicrob Chemother (1986) 1.34
Epidemiology of Salmonella typhimurium O:4-12 infection in Norway: evidence of transmission from an avian wildlife reservoir. Am J Epidemiol (1998) 1.31
Characterization of Micrococcaceae from the urinary tract. Acta Pathol Microbiol Scand B (1975) 1.28
Epidemiological aspects of enteritis due to Campylobacter spp. in Norway. J Clin Microbiol (1984) 1.27
Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis (1994) 1.24
In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim. Chemotherapy (1985) 1.19
Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice? APMIS (1999) 1.17
Societal aspects of genetically modified foods. Food Chem Toxicol (2004) 1.13
Outbreak of Salmonella typhimurium infection traced to contaminated chocolate and caused by a strain lacking the 60-megadalton virulence plasmid. J Clin Microbiol (1990) 1.13
Serotype-related HEp-2 cell interaction of Yersinia enterocolitica. Infect Immun (1986) 1.13
Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals. J Antimicrob Chemother (2003) 1.13
Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics". Scand J Infect Dis Suppl (1997) 1.12
Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. Acta Pathol Microbiol Immunol Scand C (1985) 1.12
Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol (2000) 1.11
Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study. Epidemiol Infect (1994) 1.10
Bacterial adhesiveness and invasiveness in cell culture monolayer. Acta Pathol Microbiol Immunol Scand B (1982) 1.09
Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol (1989) 1.08
Actinobacillus lignieresii infection after a horse bite. Br Med J (Clin Res Ed) (1981) 1.06
Common enterobacterial antigen in Yersinia enterocolitica. Acta Pathol Microbiol Scand B (1975) 1.04
Effects of carbon dioxide upon the in vitro activity of erythromycin. Acta Pathol Microbiol Immunol Scand B (1986) 1.04
Equal symptomatic outcome after antibacterial treatment of acute lower urinary tract infection and the acute urethral syndrome in adult women. Scand J Prim Health Care (1999) 1.04
Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient. Scand J Infect Dis (1994) 1.04
Yersinia enterocolitica type 2 associated with disease in goat. Acta Vet Scand (1972) 1.03
Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care (1994) 1.02
Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis (1992) 1.02
Clinical features of sporadic Yersinia enterocolitica infections in Norway. J Infect Dis (1992) 1.01
Exposure to bacterial aerosols and work-related symptoms in sewage workers. Am J Ind Med (1994) 1.01
Plasmid characterization of Salmonella typhimurium transmitted from animals to humans. J Clin Microbiol (1985) 1.00
Erysipelas-like disease caused by Yersinia enterocolitica. Scand J Infect Dis (1974) 0.99
Bacteriological findings in urine specimens from women. Association with urinary tract symptoms and sampling methods. Scand J Urol Nephrol (1991) 0.98
Serotyping and biotyping of Campylobacter jejuni and Campylobacter coli from sporadic cases and outbreaks in Norway. J Clin Microbiol (1984) 0.98
Emerging antibiotic resistance in Salmonella typhimurium in Norway. Epidemiol Infect (2000) 0.97
Salmonella infections in Norway: descriptive epidemiology and a case-control study. Epidemiol Infect (1998) 0.96
Importance of selective media for recovery of yeasts from clinical specimens. J Clin Microbiol (1999) 0.95
An ELISA study of the antibody response after vaccination with a combined meningococcal group B polysaccharide and serotype 2 outer membrane protein vaccine. NIPH Ann (1983) 0.95
Penetration of antibiotics into human leukocytes and dermal suction blisters. Rev Infect Dis (1983) 0.95
Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect (2001) 0.95
Bacterial adhesiveness and invasiveness in cell culture monolayer. 2. In vitro invasiveness of 45 strains belonging to the family Enterobacteriaceae. Acta Pathol Microbiol Immunol Scand B (1982) 0.94
Assessing financial position with 29 key ratios. Hosp Financ Manage (1980) 0.93
Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium. Clin Microbiol Infect (2000) 0.92
Transtracheal aspiration in the diagnosis of lower respiratory tract infections. Scand J Infect Dis (1972) 0.92
A survey of acute and chronic disease associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients. Scand J Infect Dis (1991) 0.91
Measurement of the first ionization potential of astatine by laser ionization spectroscopy. Nat Commun (2013) 0.91
First observation of atomic levels for the element fermium (Z=100). Phys Rev Lett (2003) 0.90
Reiter's disease following Yersinia enterocolitica infection. Scand J Infect Dis (1971) 0.89
Implications of probability analysis for interpreting results of leukocyte esterase and nitrite test strips. Clin Chem (1989) 0.89
Assessment of clinical features predicting streptococcal pharyngitis. Scand J Infect Dis (1993) 0.88
Isolation of Yersinia enterocolitica from a dog with chronic enteritis: a case report. Acta Vet Scand (1976) 0.88
Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic. Eur J Clin Microbiol Infect Dis (2013) 0.87
Bacteriological findings in transtracheal aspirates from patients with chronic bronchitis and bronchiectasis: a preliminary report. Scand J Respir Dis (1975) 0.87
Acute and chronic gastrointestinal manifestations associated with Yersinia enterocolitica infection. A Norwegian 10-year follow-up study on 458 hospitalized patients. Ann Surg (1992) 0.86
Bacteriuria in patients treated with clean intermittent catheterization. Scand J Infect Dis (1991) 0.86
Comparison of the indirect haemagglutination and dye test for detection of antibodies to Toxoplasma gondii. Scand J Infect Dis (1974) 0.86
[Value of transtracheal aspiration in bronchopulmonary infections in adults]. Infection (1973) 0.86
Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients. Scand J Infect Dis (1998) 0.86
The effect of referral for brief intervention for alcohol misuse on repetition of deliberate self-harm: an exploratory randomized controlled trial. Psychol Med (2010) 0.85
The N/F and Oxi/Ferm systems for identification of oxidative-fermentative Gram-negative rods: a comparative study. Acta Pathol Microbiol Immunol Scand B (1982) 0.85
Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiol Infect (1999) 0.84
Outbreak of Salmonella Livingstone infection in Norway and Sweden due to contaminated processed fish products. Epidemiol Infect (2004) 0.84
The value of cows in reference populations for genomic selection of new functional traits. Animal (2012) 0.84
Yersinia enterocolitica infection. Lancet (1973) 0.83
Physical predictors of infection in patients treated with clean intermittent catheterization: a prospective 7-year study. Br J Urol (1997) 0.83
The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. Scand J Infect Dis Suppl (1980) 0.83
Therapy of staphylococcal septicaemia in compromised hosts. Scand J Infect Dis Suppl (1983) 0.82
A unique plasmid profile characterizing Salmonella enteritidis isolates from patients and employees in a hospital. APMIS (1990) 0.82
Detection and quantitation of antibodies against Rhizopus by enzyme-linked immunosorbent assay. APMIS (1992) 0.82
Udder health and female fertility traits are favourably correlated and support each other in multi-trait evaluations. J Anim Breed Genet (2010) 0.82
[The contaminated chocolate epidemic of 1987]. Tidsskr Nor Laegeforen (1989) 0.82
Cefotaxime in serious infections--a clinical and pharmacokinetic study. J Antimicrob Chemother (1982) 0.82
The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals. J Hosp Infect (2002) 0.81
Outbreak of Salmonella Kedougou in Norway associated with salami, April-June 2006. Euro Surveill (2006) 0.81
Human serum antibodies against heat-stable antigens from Yersinia enterocolitica. Acta Pathol Microbiol Scand B (1975) 0.81
The pharmacokinetics of ceftriaxone in serum, skin blister and thread fluid. J Antimicrob Chemother (1984) 0.81
Pharmacokinetics of ampicillin in serum and in dermal suction blisters after oral administration of bacampicillin. Rev Infect Dis (1981) 0.81
Emerging Salmonella Enteritidis anaerogenic phage type 14b: outbreak in Norwegian, Swedish and Finnish travellers returning from Greece. Euro Surveill (2006) 0.80
Bacteriological findings in the transtracheal aspirate from patients with acute exacerbation of chronic bronchitis. Infection (1978) 0.80
Bladder irrigation in patients with indwelling catheters. Scand J Infect Dis (1978) 0.80
Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa. J Reprod Immunol (1995) 0.80
Characteristics of 20 human Pasteurella isolates from animal bite wounds. Acta Pathol Microbiol Scand B (1981) 0.80
Antimicrobial resistance in Campylobacter jejuni from humans and broilers in Norway. Epidemiol Infect (2006) 0.80
Hyperbaric oxygen therapy in bacteroides infections. Acta Chir Scand (1974) 0.79
Genetic parameters for female fertility, locomotion, body condition score, and linear type traits in Czech Holstein cattle. J Dairy Sci (2011) 0.79
[Global transmission of Salmonella--increased risk in Norway. Interdisciplinary measures are necessary to maintain Norway's favourable situation]. Tidsskr Nor Laegeforen (1994) 0.79
Lay and expert perceptions of zoonotic risks: understanding conflicting perspectives in the light of moral theory. Int J Food Microbiol (2005) 0.79
N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates. Acta Pathol Microbiol Immunol Scand B (1983) 0.79